In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease.
about
Recombinant human interleukin 10 for induction of remission in Crohn's diseaseInterleukin 10 in Helicobacter pylori associated gastritis: immunohistochemical localisation and in vitro effects on cytokine secretionInflammatory bowel diseaseIL-1beta and IL-10 have dual effects on enteric glial cell proliferation.Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats.Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease.Could the airway epithelium play an important role in mucosal immunoglobulin A production?The key role of macrophages in the immunopathogenesis of inflammatory bowel disease.Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.Review article: the immunoregulatory cytokine interleukin-10--a therapy for Crohn's disease?Immunotherapeutic approaches to inflammatory bowel diseases.The germless theory of allergic disease: revisiting the hygiene hypothesis.Initiation of an inflammatory response in resident intestinal lamina propria cells -use of a human organ culture model.Interleukin-10-based therapy for inflammatory bowel disease.Posttranslationally modified proteins as mediators of sustained intestinal inflammation.Differential expression and upregulation of interleukin-1alpha, interleukin-1beta and interleukin-6 by freshly isolated human small intestinal epithelial cells.Immunopathogenesis of IBD: current state of the art.New developments in goblet cell mucus secretion and functionMucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants.Vitamin A rewrites the ABCs of oral tolerance.T cell-mediated immunoregulation in the gastrointestinal tract.Interleukin-10 is produced by a specific subset of taste receptor cells and critical for maintaining structural integrity of mouse taste buds.Gatekeepers of intestinal inflammation.Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?CD4⁺ T cell cytokine gene and protein expression in duodenal mucosa of dogs with inflammatory bowel disease.Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.Patients with inflammatory bowel disease may have a transforming growth factor-beta-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies.The IL-10R1 S138G loss-of-function allele and ulcerative colitis.Human intestinal epithelial cells express interleukin-10 through Toll-like receptor 4-mediated epithelial-macrophage crosstalk.TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD.Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling.Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.Thiol-mediated redox regulation of intestinal lamina propria T lymphocytesFrequency of CD4+CD161+ T Cell and Interleukin-10 Expression in Inflammatory Bowel Diseases.CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNFT cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation.Environmental and genetic factors influence the relationship between circulating IL-10 and obesity phenotypes.Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease.Total glucosides of peony attenuates 2,4,6-trinitrobenzene sulfonic acid/ethanol-induced colitis in rats through adjustment of TH1/TH2 cytokines polarization.
P2860
Q24236636-AEC12761-B5B0-4202-A801-E1B74C21C6A9Q28362741-CF9DEFAD-F858-4FAC-B29A-C9CD67133339Q29615500-93B60298-FA89-4EA4-A13F-823F60CF3FB8Q31907584-A76B1275-1AD7-49EB-847C-C257653B4D1DQ33261861-BA713A00-E91C-42EA-89AC-7FEB1D46B44EQ33618861-8D50A25C-7EEE-4174-A047-28831DF6D971Q33792418-342EAF3E-B5D6-4303-A34A-28185CB4296FQ33853551-AAA6ED1B-7602-477A-98ED-CE84327D95D5Q34382826-5A60E1B2-6046-43EE-ABCF-9172C68DC797Q34421477-ED44F3A3-F241-46E5-8BC8-04BB0E27ABF4Q34451989-26F0B274-B9B9-4CFB-81DD-21464225ACD1Q34572144-99C46033-357F-4190-B024-5E14E52615CCQ35171067-1756136E-E0FA-49A2-9B8A-3CFC84900565Q35184708-37271013-F3DE-44FC-B315-B38A5012B5CEQ35607249-F5411B8C-8E30-41A4-B534-608ADE252625Q35609508-5899507E-A45E-4138-A660-05271C7783C2Q35857951-F51F0AB8-5AB7-4040-8210-5F7594CBAE64Q36245309-9589E7F8-78F0-48F9-8A0A-B1479718ACA7Q36439020-C4E5075D-20D2-4EF9-8862-BC8426A85953Q37349701-44FD7221-0E7E-4F29-B835-A9C289A00A56Q37390806-17DF2D11-F726-4F9C-831B-435A29BE9AAFQ37578470-1B025FEE-691E-45AD-9AA9-AA9ECE4C5B78Q37672486-AC613748-49A9-4026-8218-6DED4FAF9ECFQ37762230-FC3A6654-04E4-4A89-B0D9-4AB30D39A25CQ39348680-BDCA56A7-39E4-426F-AF1E-FF1A099DE2AEQ39546806-4BE93D0B-01FE-4DFA-8072-A140B5475AFDQ39905740-467008AE-08A6-4E9E-9BA8-95695BED71C3Q39938602-6D6F9DEB-CC41-4C93-ACA4-D7743A73B17CQ39941759-49D402A1-B6D3-464D-A5CF-C156F52FA925Q39947013-4359BD66-E524-40A1-BAEC-9961CF80F2DFQ40002459-83043652-F99E-46E0-8EF7-7BDC783961E4Q40104157-875EC8FA-2A74-409C-B916-8C9DEA4424CFQ40481891-E560ACB4-6D21-486E-B7A0-E6B864E649BEQ41906254-DD796ABB-E73F-4588-B5DF-C6A9DB7FCA26Q42002157-2C562FBF-A402-4089-A8FA-99A07A2039C7Q42142744-D621F57B-348C-43BA-9455-6AA158DA832DQ42971196-9BCDF33C-D5B6-4E94-B378-E920E15CC162Q43268257-3F3B2D9B-E898-4771-9B3B-529B39A37D9AQ48030169-EC118880-F4DB-4920-91CD-3C7E9992B7BAQ50903350-5862F2A3-4C0D-4AA8-BCF5-1EEC240CA88E
P2860
In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
In situ expression of interleu ...... in inflammatory bowel disease.
@ast
In situ expression of interleu ...... in inflammatory bowel disease.
@en
type
label
In situ expression of interleu ...... in inflammatory bowel disease.
@ast
In situ expression of interleu ...... in inflammatory bowel disease.
@en
prefLabel
In situ expression of interleu ...... in inflammatory bowel disease.
@ast
In situ expression of interleu ...... in inflammatory bowel disease.
@en
P2093
P2860
P1476
In situ expression of interleu ...... in inflammatory bowel disease.
@en
P2093
F Autschbach
G Schürmann
J Braunstein
Z I Niemir
P2860
P304
P356
10.1016/S0002-9440(10)65552-6
P407
P577
1998-07-01T00:00:00Z